Shareholders meeting

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in Date: September 18, 2026 The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 541540, 890202 Scrip Code: SOLARA, SOLARAPP1 Dear Sir / Madam, Subject: Proceedings of the Ninth Annual General Meeting of the Company and disclosure under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We wish to inform you that the Ninth Annual General Meeting (“AGM”) of the Company was held on Friday, September 18, 2026, at 10.30 A.M. IST through video conferencing and ended at 11.40 A.M. IST. Pursuant to Regulation 30, Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed summary of proceedings of the AGM. This is for your information and records. Thanking you, Yours faithfully, For Solara Active Pharma Sciences Limited Pooja Jaya Kumar Company Secretary and Compliance Officer ICSI Membership No.: A57415 Encl.: as above Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703 / Tel: +91-22-2789 2924 Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in SUMMARY OF PROCEEDINGS OF THE NINTH ANNUAL GENERAL MEETING OF THE COMPANY HELD ON FRIDAY, SEPTEMBER 18, 2026, FROM 10:30 A.M. TO 11:40 A.M. THROUGH VIDEO CONFERENCE Ms. Pooja Jaya Kumar, Company Secretary & Compliance Officer of the Company, welcomed the Members to the Ninth Annual General Meeting (AGM) of the Company which was held through video conference and in compliance with the applicable provisions of the Companies Act, 2013 read with the Rules framed thereunder, Secretarial Standards, SEBI Listing Regulations, 2015 and various applicable Circulars issued by MCA and SEBI in this regard. Thereafter, Board members, Management and other Invitees present at the meeting were introduced and the following was noted: Directors and Management present The following Directors and Management officials attended the meeting: Mr. R. Ramakrishnan Independent Director & Chairman of the Board, Audit Committee Independent Director & Chairperson of Stakeholders Dr. Kausalya Santhanam Relationship Committee & CSR Committee Independent Director & Chairman of Nomination and Dr. Rajendra Kumar Srivastava Remuneration Committee Mr. Rajiv Vijay Nabar Independent Director, Chairman of Risk Management Committee Mr. Manish Gupta Non-Executive Director Mr. Sandeep Shashikantha Rao Managing Director & Chief Executive Officer (CEO) Mr. Mohanraj Sanjeevi Whole Time Director & Chief Human Resources Officer (CHRO) Mr. Sarat Kumar Asuri Chief Financial Officer (CFO) Ms. Pooja Jaya Kumar Company Secretary & Compliance Officer Mr. Raghavan Venkatramani Assistant Vice President - Accounts Other Invitees present The representatives of Deloitte Haskins & Sells LLP, Chartered Accountants, Statutory Auditors; Grant Thornton Bharat LLP, Internal Auditors; Mrs. Parimala Natrajan, the Secretarial Auditor; and Mr. Preetham Hebbar, Practising Company Secretary, Scrutinizer for the e-voting process and Mr. Nagaraj V, Cameo Corporate Services Limited, Registrar and Share Transfer Agent of the Company were present at the meeting. Quorum and commencement of meeting Ms. Pooja Jaya Kumar confirmed to the Chairman that the requisite quorum was present and requested the Chairman to chair the meeting. Mr. R. Ramakrishnan chaired the meeting, called the meeting to order and greeted the shareholders. Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703 / Tel: +91-22-2789 2924 Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in The Chairman thereafter invited Mr. Sandeep Shashikantha Rao, Managing Director & CEO, to address the shareholders and present the financial and operational performance of the Company for Financial Year 2025-26. Mr. Sandeep Shashikantha Rao, Managing Director & CEO and Mr. Sarat Kumar Asuri, CFO, presented the financial and business performance of the Company. Thereafter, Ms. Pooja Jaya Kumar, the Company Secretary, invited queries from shareholders registered as speakers with the Company. The queries raised by the shareholders were suitably responded to by Mr. Sandeep Shashikantha Rao and Mr. Sarat Kumar Asuri. The AGM Notice convening the meeting, the Board’s Report and the Auditor’s Report for the financial year ended March 31, 2026, were taken as read, as these documents had already been circulated to the shareholders. The shareholders were informed that the Auditor’s Reports on the Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, did not contain any qualification, observation or adverse remarks. The shareholders were informed that the requisite Statutory Registers along with the certificate from Ms. Parimala Natrajan, Secretarial Auditor of the Company, certifying that the ESOP Schemes of the Company have been implemented in accordance with the SEBI Regulations and in accordance with the Shareholders’ approval were open for e-inspection. Business transacted at the AGM The following items of business as set out in the Notice of AGM dated August 21, 2026, were transacted at the meeting: Item Description / Resolutions Type of Resolution Ordinary Business Adoption of Audited Standalone Financial Statements of the 1 Ordinary Resolution Company for the financial year ended March 31, 2026 Adoption of Audited Consolidated Financial Statements of the 2 Ordinary Resolution Company for the financial year ended March 31, 2026 Appointment of Mr. Arun Kumar Pillai (DIN: 00084845), who 3 Ordinary Resolution retires by rotation, as a Non-Executive Director of the Company Special Business Ratification of the remuneration payable to the Cost Auditor for 4 Ordinary Resolution the financial year 2026-27 Approval for Material Related Party Transactions/ Contracts/ 5 Arrangements with Strides Pharma Science Limited up to Rs. 480 Ordinary Resolution crores E-voting at the AGM and declaration of results It was informed that shareholders who had not cast their votes through remote e-voting were provided the facility to cast their vote electronically at the meeting for the next 30 minutes. Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703 / Tel: +91-22-2789 2924 Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in Shareholders were further informed that the voting results, along with the Scrutinizer’s Report, would be declared within two working days from the conclusion of the AGM, i.e., on or before Tuesday, September 22, 2026, and would be posted on the Company’s website and RTA’s website and the same shall be filed with both the Stock Exchanges. Mr. R. Ramakrishnan, Chairman, thanked the Members and concluded the meetin [Showing first 8,000 characters — download PDF for full document]